MIST1 Inhibitors
MIST1, also known as BHLHA15, is a transcription factor primarily expressed in secretory cells of exocrine glands, including pancreatic acinar cells, gastric chief cells, and salivary gland acinar cells. Its main function is to regulate the differentiation and maturation of these secretory cells, thereby playing a crucial role in the maintenance of exocrine tissue homeostasis and function. MIST1 is involved in orchestrating various cellular processes essential for secretory cell development and function, such as exocytosis, protein synthesis and trafficking, as well as the synthesis of digestive enzymes in pancreatic acinar cells. Moreover, MIST1 is implicated in the regulation of cell polarity and morphology, which are vital for the proper formation and functioning of secretory glands.
Inhibition of MIST1 function can disrupt the normal development and function of exocrine glands, leading to pathological conditions. Several mechanisms can be involved in the inhibition of MIST1 activity. One mechanism is the interference with MIST1 protein expression or stability, which can be achieved through various molecular pathways, such as the inhibition of its transcription or post-translational modifications. Additionally, inhibition of MIST1 DNA-binding activity or its interaction with co-factors required for transcriptional regulation can also impair its function. Furthermore, disruption of downstream signaling pathways essential for MIST1-mediated gene expression can result in inhibition of its activity. Overall, inhibition of MIST1 function can lead to defective differentiation and maturation of secretory cells, aberrant secretion of digestive enzymes, and disruption of tissue homeostasis in exocrine glands.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a specific p38 MAPK inhibitor, targets the p38 signaling pathway. MIST1 is known to interact with p38 MAPK, and the inhibition of this pathway by SB203580 indirectly suppresses MIST1 activity. The dampening of p38 MAPK signaling disrupts downstream events that contribute to MIST1 function, influencing cellular processes related to differentiation and homeostasis. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits phosphoinositide 3-kinase (PI3K), a key regulator of the AKT signaling pathway. By disrupting PI3K activity, LY294002 indirectly influences MIST1, as AKT signaling plays a role in MIST1 regulation. This inhibition impacts cellular processes associated with MIST1, including its involvement in pancreatic acinar cell function and differentiation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, like LY294002, inhibits PI3K, disrupting AKT signaling. This inhibition indirectly affects MIST1, as AKT is implicated in the regulation of MIST1 activity. The modulation of AKT signaling by Wortmannin influences cellular processes governed by MIST1, including its role in pancreatic acinar cell differentiation and function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor that targets the JNK signaling pathway. MIST1 has known interactions with JNK, and the inhibition of JNK by SP600125 indirectly modulates MIST1 activity. The suppression of JNK signaling disrupts downstream events that contribute to MIST1 function, impacting cellular processes related to acinar cell differentiation and pancreatic function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a key player in the mTOR signaling pathway. MIST1 is implicated in pathways regulated by mTOR. The inhibition of mTOR by Rapamycin indirectly influences MIST1, as mTOR signaling is connected to MIST1 activity. This modulation affects cellular processes associated with MIST1, including its role in pancreatic acinar cell differentiation and function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a specific MEK1 inhibitor targeting the MAPK/ERK pathway. MIST1 is linked to the MAPK/ERK pathway, and the inhibition of this pathway by PD98059 indirectly influences MIST1. The altered MAPK/ERK signaling disrupts downstream events that impact MIST1 function, influencing cellular processes associated with MIST1, such as the regulation of acinar cell differentiation. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
Tyrphostin B42 (AG490) is a JAK2 inhibitor targeting the JAK/STAT pathway. MIST1 is influenced by STAT signaling. The inhibition of JAK2 by AG490 indirectly modulates MIST1, disrupting downstream events associated with MIST1 function and influencing cellular processes related to acinar cell differentiation and pancreatic function. | ||||||
GDC-0941 | 957054-30-7 | sc-364498 sc-364498A | 5 mg 10 mg | $188.00 $199.00 | 2 | |
GDC-0941 is a pan-PI3K inhibitor, targeting the PI3K/AKT pathway. MIST1 is connected to the PI3K/AKT pathway, and the inhibition of this pathway by GDC-0941 indirectly influences MIST1. The altered PI3K/AKT signaling disrupts downstream events that impact MIST1 function, influencing cellular processes associated with MIST1, including its role in pancreatic acinar cell differentiation. | ||||||
Tyrphostin AG 1478 | 175178-82-2 | sc-200613 sc-200613A | 5 mg 25 mg | $96.00 $421.00 | 16 | |
AG-1478 is an EGFR tyrosine kinase inhibitor targeting the EGFR signaling pathway. MIST1 is implicated in pathways influenced by EGFR. The inhibition of EGFR by AG-1478 indirectly modulates MIST1, disrupting downstream events associated with MIST1 function and influencing cellular processes related to acinar cell differentiation and pancreatic function. | ||||||
IKK-2 Inhibitor IV | 507475-17-4 | sc-203083 | 500 µg | $133.00 | 12 | |
Also called TPCA-1, this compound is an IKK-2 inhibitor targeting the NF-κB signaling pathway. MIST1 is known to interact with NF-κB signaling. The inhibition of IKK-2 by TPCA-1 indirectly influences MIST1, disrupting downstream events associated with MIST1 function and influencing cellular processes related to acinar cell differentiation and pancreatic function. | ||||||